What Is the Role of Advanced Lipoprotein Analysis in Practice?
Abstract
No abstract availableKeywords
Funding Information
- Amgen
- Daiichi-Sankyo
- Esperion
- GlaxoSmithKline
- Merck
- Sanofi Aventis
This publication has 56 references indexed in Scilit:
- Treatment of adults with Familial Hypercholesterolemia and evidence for treatment: Recommendations from the National Lipid Association Expert Panel on Familial HypercholesterolemiaJournal of Clinical Lipidology, 2011
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)European Heart Journal, 2011
- 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic AdultsJACC, 2010
- Advanced Lipoprotein Testing and Subfractionation Are Clinically UsefulCirculation, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Lipoprotein Management in Patients With Cardiometabolic RiskJACC, 2008
- Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy: part IJournal of Lipid Research, 2004
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatmentThe Lancet, 2003
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final ReportCirculation, 2002